Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	98.78	138.89	69.87
Graham Fair Price	102.16	233.75	115.63
PEG	-96.16	0.03	-0.88
Price/Book	9.66	4.21	3.84
Price/Cash Flow	1499.59	-1334.04	83.40
Prices/Earnings	-67.25	8.94	27.29
Price/Sales	55.74	29.86	19.17
Price/FCF	1499.59	-1334.04	83.40
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-27.68	0.22	0.30
Operating Margin	-45.73	0.12	0.23
ROA	252.59	0.06	0.02
ROE	0.04	0.12	234.83
ROIC	0.02	< 0.005	-65.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.13	-72.38
Dividends QOQ	< 0.005	< 0.005	99.56
EBIT QOQ	-0.36	-0.58	-62.24
EPS QOQ	-0.31	2.63	751.82
FCF QOQ	0.30	-1.08	252.73
Revenue QOQ	-0.19	-0.22	-14.77
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	79.11	99.01	25.16
Days Sales Outstanding (DSO)	42.16	50.58	19.97
Inventory Turnover	1.14	0.91	-20.10
Debt/Capitalization	0.35	0.33	-6.61
Quick Ratio	1.74	2.35	34.89
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	129.99	143.61	10.48
Cash	20.75	42.88	106.66
Capex	-3.01	-3.24	-7.41
Free Cash Flow	5.98	-0.45	-92.43
Revenue	26.02	20.24	-22.21
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.35	3.16	-5.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.38	7.37	-0.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating